Your browser doesn't support javascript.
loading
Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image Guided Radiation Therapy Without Hormone Therapy.
Berlin, Alejandro; Murgic, Jure; Hosni, Ali; Pintilie, Melania; Salcedo, Adriana; Fraser, Michael; Kamel-Reid, Suzanne; Zhang, Jingbin; Wang, Qiqi; Ch'ng, Carolyn; Deheshi, Samineh; Davicioni, Elai; van der Kwast, Theodorus; Boutros, Paul C; Bristow, Robert G; Chua, Melvin L K.
Afiliación
  • Berlin A; Princess Margaret Cancer Centre, University Health Network, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Ontario, Canada; Techna Institute, University Health Network, Ontario, Canada. Electronic address: alejandroberlin@gmail.com.
  • Murgic J; Princess Margaret Cancer Centre, University Health Network, Ontario, Canada.
  • Hosni A; Princess Margaret Cancer Centre, University Health Network, Ontario, Canada.
  • Pintilie M; Princess Margaret Cancer Centre, University Health Network, Ontario, Canada.
  • Salcedo A; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Ontario, Canada.
  • Fraser M; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Ontario, Canada.
  • Kamel-Reid S; Laboratory Medicine Program, University Health Network, Ontario, Canada.
  • Zhang J; GenomeDx Biosciences Inc., Vancouver, British Columbia, Canada.
  • Wang Q; GenomeDx Biosciences Inc., Vancouver, British Columbia, Canada.
  • Ch'ng C; GenomeDx Biosciences Inc., Vancouver, British Columbia, Canada.
  • Deheshi S; GenomeDx Biosciences Inc., Vancouver, British Columbia, Canada.
  • Davicioni E; GenomeDx Biosciences Inc., Vancouver, British Columbia, Canada.
  • van der Kwast T; Laboratory Medicine Program, University Health Network, Ontario, Canada.
  • Boutros PC; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Ontario, Canada.
  • Bristow RG; Princess Margaret Cancer Centre, University Health Network, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Ontario, Canada; Manchester Cancer Research Centre, Manchester, United Kingdom.
  • Chua MLK; Princess Margaret Cancer Centre, University Health Network, Ontario, Canada; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore; Division of Medical Sciences, National Cancer Centre Singapore, Singapore; Oncology Academic Program, Duke-NUS Medical School, Singapore.
Int J Radiat Oncol Biol Phys ; 103(1): 84-91, 2019 01 01.
Article en En | MEDLINE | ID: mdl-30170099
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Radioterapia Guiada por Imagen Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Radioterapia Guiada por Imagen Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2019 Tipo del documento: Article